The Risk of Acute Pancreatitis and Selective Serotonin Reuptake Inhibitors Use: A Meta-Analysis of Case-Control Studies

被引：1

作者：

Lai, Shih-Wei ^{[1
,2
]}

Yu, Cheng-Chan ^{[3
]}

Lin, Cheng-Li ^{[4
]}

Liao, Kuan-Fu ^{[5
,6
]}

机构：

[1] China Med Univ, Coll Med, Taichung, Taiwan

[2] China Med Univ Hosp, Dept Family Med, Taichung, Taiwan

[3] Taichung Tzu Chi Hosp, Dept Gen Surg, Taichung, Taiwan

[4] China Med Univ Hosp, Management Off Hlth Data, Taichung, Taiwan

[5] Tzu Chi Univ, Coll Med, Hualien, Taiwan

[6] Taichung Tzu Chi Hosp, Dept Internal Med, Div Hepatogastroenterol, Taichung, Taiwan

来源：

DOSE-RESPONSE | 2020年 / 18卷 / 01期

关键词：

acute pancreatitis; selective serotonin reuptake inhibitors; ETIOLOGY;

D O I：

10.1177/1559325820902352

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

Background/Objective: Some case series and case report have shown the association between the risk of acute pancreatitis and use of selective serotonin reuptake inhibitors. The results of systematic studies were not consistent. Methods: A meta-analysis was performed to investigate the risk of acute pancreatitis associated with use of selective serotonin reuptake inhibitors. Results: There was no statistical association between the risk of acute pancreatitis and selective serotonin reuptake inhibitors use (odds ratio: 1.19, 95% confidence interval: 0.93-1.51). Conclusions: Despite reaching no statistical significance, the possibility of the association between the risk of acute pancreatitis and selective serotonin reuptake inhibitors use cannot be totally excluded.

引用

页数：4

共 23 条

[1] Drug-induced acute pancreatitis: An evidence-based review [J].